Treasurer of the State of North Carolina’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19M Sell
58,304
-651
-1% -$212K 0.06% 292
2025
Q1
$15.9M Sell
58,955
-27,960
-32% -$7.55M 0.06% 266
2024
Q4
$20.5M Buy
86,915
+2,310
+3% +$544K 0.08% 228
2024
Q3
$23.3M Buy
84,605
+5,040
+6% +$1.39M 0.09% 200
2024
Q2
$19.3M Sell
79,565
-7,822
-9% -$1.9M 0.08% 215
2024
Q1
$13.1M Buy
87,387
+690
+0.8% +$103K 0.06% 311
2023
Q4
$16.6M Buy
86,697
+740
+0.9% +$142K 0.08% 245
2023
Q3
$15.2M Sell
85,957
-960
-1% -$170K 0.08% 246
2023
Q2
$16.5M Sell
86,917
-1,560
-2% -$296K 0.09% 228
2023
Q1
$17.7M Buy
88,477
+2,110
+2% +$423K 0.1% 205
2022
Q4
$20.5M Buy
86,367
+1,880
+2% +$447K 0.13% 170
2022
Q3
$16.9M Buy
84,487
+500
+0.6% +$100K 0.11% 180
2022
Q2
$12.3M Buy
83,987
+6,428
+8% +$938K 0.08% 253
2022
Q1
$12.7M Buy
77,559
+1,775
+2% +$290K 0.07% 260
2021
Q4
$12.9M Sell
75,784
-520
-0.7% -$88.2K 0.07% 273
2021
Q3
$14.4M Buy
76,304
+3,329
+5% +$629K 0.08% 224
2021
Q2
$12.4M Buy
72,975
+1,010
+1% +$171K 0.07% 250
2021
Q1
$10.2M Sell
71,965
-587
-0.8% -$82.9K 0.06% 288
2020
Q4
$9.43M Buy
72,552
+1,100
+2% +$143K 0.06% 297
2020
Q3
$10.4M Buy
71,452
+4,250
+6% +$619K 0.08% 232
2020
Q2
$9.95M Buy
67,202
+13,385
+25% +$1.98M 0.08% 220
2020
Q1
$5.86M Buy
53,817
+18,910
+54% +$2.06M 0.05% 316
2019
Q4
$4.02M Sell
34,907
-6,340
-15% -$730K 0.03% 368
2019
Q3
$3.32M Sell
41,247
-23,663
-36% -$1.9M 0.03% 410
2019
Q2
$4.71M Sell
64,910
-665
-1% -$48.3K 0.03% 491
2019
Q1
$6.13M Buy
65,575
+1,510
+2% +$141K 0.04% 391
2018
Q4
$4.67M Buy
64,065
+1,137
+2% +$82.9K 0.03% 434
2018
Q3
$5.51M Buy
62,928
+41,856
+199% +$3.66M 0.03% 435
2018
Q2
$2.08M Buy
21,072
+11,826
+128% +$1.16M 0.02% 574
2018
Q1
$1.1M Buy
+9,246
New +$1.1M 0.03% 547